Impact of PSMA PET Staging on Initial Treatment in Newly Diagnosed Prostate Cancer
{{output}}
Prostate-specific membrane antigen (PSMA) PET/CT has become a common staging modality for newly diagnosed high-risk and unfavorable intermediate-risk prostate cancer after showing improved sensitivity and specificity compared with conventional imaging in clini... ...
